Invesco Dorsey Wright Emerging Markets Momentum ETF (PIE)
NASDAQ: PIE · Real-Time Price · USD
34.55
+0.51 (1.51%)
Sep 25, 2026, 4:00 PM EDT - Market closed
| Assets | $254.29M |
| Expense Ratio | 0.90% |
| PE Ratio | 18.28 |
| Shares Out | 7.50M |
| Dividend (ttm) | $0.74 |
| Dividend Yield | 2.16% |
| Ex-Dividend Date | Sep 21, 2026 |
| Payout Frequency | Quarterly |
| Payout Ratio | 39.42% |
| Volume | 26,524 |
| Open | 34.42 |
| Previous Close | 34.04 |
| Day's Range | 34.23 - 34.63 |
| 52-Week Low | 22.58 |
| 52-Week High | 35.17 |
| Beta | 0.87 |
| Holdings | 114 |
| Inception Date | Dec 28, 2007 |
About PIE
Fund Home PageThe Invesco Dorsey Wright Emerging Markets Momentum ETF (PIE) is an exchange-traded fund that mostly invests in total market equity. The fund tracks an index of stocks in emerging markets that show high relative strength characteristics. PIE was launched on Dec 28, 2007 and is issued by Invesco.
Asset Class Equity
Category Diversified Emerging Mkts
Region Global
Stock Exchange NASDAQ
Ticker Symbol PIE
ETF Provider Invesco
Index Tracked Dorsey Wright Emerging Markets Technical Leaders Index (Net)
Top 10 Holdings
25.06% of assets| Name | Symbol | Weight |
|---|---|---|
| Wanguo Gold Group Limited | 3939 | 3.07% |
| Topco Scientific Co.,Ltd. | 5434 | 2.85% |
| Taiwan Semiconductor Manufacturing Company Limited | 2330 | 2.77% |
| United Integrated Services Co., Ltd. | 2404 | 2.74% |
| Sigurd Microelectronics Corporation | 6257 | 2.52% |
| Marketech International Corp. | 6196 | 2.51% |
| Yankey Engineering Co., Ltd. | 6691 | 2.23% |
| Accton Technology Corporation | 2345 | 2.17% |
| Chroma ATE Inc. | 2360 | 2.13% |
| Unimicron Technology Corp. | 3037 | 2.09% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Sep 21, 2026 | $0.25747 | Sep 25, 2026 |
| Jun 22, 2026 | $0.21801 | Jun 26, 2026 |
| Mar 23, 2026 | $0.02647 | Mar 27, 2026 |
| Dec 22, 2025 | $0.24204 | Dec 26, 2025 |
| Sep 22, 2025 | $0.08093 | Sep 26, 2025 |
| Jun 23, 2025 | $0.20831 | Jun 27, 2025 |
Performance
PIE had a total return of 47.06% in the past year, including dividends. Since the fund's inception, the average annual return has been 3.27%.
News
US FDA to monitor clinical trial data in real time in pilot program aimed at speeding approvals
The U.S. Food and Drug Administration launched a pilot program on Monday aimed at allowing the agency to monitor clinical trial data in real time, a step the agency said could cut years from drug ap...
5 months ago - Reuters